Citorreduction with Chemotherapy
DOI:
https://doi.org/10.59843/2618-3692.v17.n30.21675Keywords:
Cytorreduction, peritoneal carcino-matosis, HIPEC, cytostaticsAbstract
Summar: Until recently, cancer in the peritoneal surface was associated with a poor prognosis. This extreme form of presentation of some tumors of peritoneal, digestive or gynecological origin, that are spread by transcelómica, had therapies only palliative. Currently some patients with peritoneal cancer dissemination can benefit from a treatment that combines cytoreduction surgery and intraperitoneal chemotherapy to provide a therapeutic alternative that can improve the survival time and quality of life of these individuals. This work tries to show the development and purposes of a challenging surgery in regards to our role as instrumentators, the cytorreduccion. It consists in the resection of all macroscopic disease, which is visible to the human eye without the aid of a microscope, and then the elimination of microscopic disease by the intraperitoneal use of chemotherapeutic drugs at high temperature. At present the Allende Sanatorio is the only health center in the province of Cordoba and one of the few in the country, which has a program of these characteristics.
Downloads
References
1- Instituto Nacional del Cáncer. (2012). Genética delcáncer. www.cancer.gov/espanol/cancer/causas-prevencion/genetica
2- Khanacademy Colege. El cáncer y el ciclo celular. es.khanacademy.org/science/biology/cellular-molecular-biology/stem-cells-andcancer/a/cancer. http://cnx.org/contents/185cbf87-c72e-48f5-b51e-f14f21b5eabd@9.85
3- Virginia Ruiz. (2013). Que es una Carcinomatosis peritoneal. www.radioncologa. com/ - www.radioncologa.com/2013/03/que-es-unacarcinomatosis-peritoneal/
4- (2017). http://www.hipec.com/es/ Que es el cáncer peritoneal, Diferentes orígenes posibles. http://www.hipec.com/es/cancer-peritoneal/que-es-el-cancer-peritoneal/
5- Carmignani.P, Jesús Esquive. Paul H. Sugarbaker. Revista de oncología (2003) Vol. 5. C. https://link. springer.com/article/10.1007/BF02712401
6- (Carmignani, P. “Relato oficial fisiopatología, diagnóstico y tratamiento de la carcinomatosis peritoneal”. Disponible en: www.aac.org.ar/ publicado en el año 2012. (Visitada el 9.03.2017)
7- Carmignani.(2012). Fisiopatología, diagnóstico y tratamiento de la carcinomatosis peritoneal. http://www.aac.org.ar/revista/2012/102/Abril-Mayo-Junio/carmignani.pdf - Carrillo, R. “Manejo perioperatorio de la quimioterapia intraperitoneal hipertérmica”. Disponible en: www.medigraphic.
com/pdfs/rma/cma-2014/cma143f.pdf . Publicado en el año 2014.
(Visitada el 12.04.2017) Instituto Nacional del Cáncer “Genética del cáncer”. https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica#1 [En línea]. (Visitada el 14.06.2017)
Gomez Portilla, A. et al. Pseudomixoma peritoneal: Supervivencia superior a 10 años tras citorreducción, quimioterapia intraperitoneal e hipertermia. Rev. esp. enferm. dig. [online]. 2008, vol.100, n.12 [citado 2017-08-23], pp.806-807. Disponible en: scielo. isciii.es/scielo.php?script=sci_arttext&pid=S1130-
01082008001200018&lng=es&nrm=iso>. ISSN 1130-0108. )
Laguna Sanz A, Mateo Resino, Barragan Alvaro B y col. Quimioterapia intraperitoneal hipertérmica, cuidados de enfermería en quirófano. Hospital Universitario de Fuenlabrada. Madrid España.2015. www. c o d e m . e s / a d j u n t o s / c o d e m / d o c u m e n t o s / informaciones/publico/9e8140e2-cec7-4df7-8af9-8843320f05ea/5f9833ec-659a-4f83-95af-36f6774a4187/90d890fe - d687 - 4b05 - af67 - 93ce58ee0298/90d890fe-d687-4b05-af67-93-ce58ee0298.pdf (visitada 6.3.17)
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Sanatorio Allende
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have published with this journal, accept the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.